These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16603638)

  • 1. Regulation of class II beta-tubulin expression by tumor suppressor p53 protein in mouse melanoma cells in response to Vinca alkaloid.
    Arai K; Matsumoto Y; Nagashima Y; Yagasaki K
    Mol Cancer Res; 2006 Apr; 4(4):247-55. PubMed ID: 16603638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
    Gan PP; Kavallaris M
    Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms.
    Sirotnak FM; Danenberg KD; Chen J; Fritz F; Danenberg PV
    Biochem Biophys Res Commun; 2000 Mar; 269(1):21-4. PubMed ID: 10694470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential recognition of response elements determines target gene specificity for p53 and p63.
    Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
    Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S; Frankfurter A; Correia JJ
    Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary study on molecular mechanism of curcumine anti-mouse melanoma].
    Gui F; Ma WF; Cai SH; Li XK; Tan Y; Zhou CL; Chen HY
    Zhong Yao Cai; 2008 Nov; 31(11):1685-9. PubMed ID: 19260281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment.
    Christian KJ; Lang MA; Raffalli-Mathieu F
    Mol Pharmacol; 2008 May; 73(5):1558-67. PubMed ID: 18296503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents.
    Kurtzberg LS; Roth SD; Bagley RG; Rouleau C; Yao M; Crawford JL; Krumbholz RD; Schmid SM; Teicher BA
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1029-38. PubMed ID: 19277662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
    Tang X; Molina M; Amar S
    Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional down-regulation of Bcl-2 by vinorelbine: identification of a novel binding site of p53 on Bcl-2 promoter.
    Bourgarel-Rey V; Savry A; Hua G; Carré M; Bressin C; Chacon C; Imbert J; Braguer D; Barra Y
    Biochem Pharmacol; 2009 Nov; 78(9):1148-56. PubMed ID: 19555669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of p53 binding site on the trans binding of p53 to Hsp90 beta gene].
    Chen LL; Wu NH; Shen YF; Guan XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Jun; 24(3):285-8. PubMed ID: 12905636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered molecular properties of tubulin in a multidrug-resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids.
    Pain J; Sirotnak FM; Barrueco JR; Yang CH; Biedler JL
    J Cell Physiol; 1988 Aug; 136(2):341-7. PubMed ID: 3045133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer.
    Benjamin CL; Ullrich SE; Kripke ML; Ananthaswamy HN
    Photochem Photobiol; 2008; 84(1):55-62. PubMed ID: 18173701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transcriptional inhibitory effect of hepatitis B virus X protein on the expression of p53 tumor suppression gene].
    Li J; Liu Y; Dai JZ; Xu DP; Zhang LX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):26-9. PubMed ID: 16642213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cellular chemotactic invasion by a vinca alkaloid, conophylline.
    Amino N; Ohse T; Koyano T; Umezawa K
    Anticancer Res; 1996; 16(1):55-9. PubMed ID: 8615670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53.
    Song LL; Alimirah F; Panchanathan R; Xin H; Choubey D
    Mol Cancer Res; 2008 Nov; 6(11):1732-41. PubMed ID: 18974396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.
    Gökmen-Polar Y; Escuin D; Walls CD; Soule SE; Wang Y; Sanders KL; Lavallee TM; Wang M; Guenther BD; Giannakakou P; Sledge GW
    Cancer Res; 2005 Oct; 65(20):9406-14. PubMed ID: 16230404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Populations of p53 codon 270 CGT to TGT mutant cells in SKH-1 mouse skin tumors induced by simulated solar light.
    Verkler TL; Delongchamp RR; Couch LH; Miller BJ; Warbritton A; Mellick PW; Howard PC; Parsons BL
    Mol Carcinog; 2008 Nov; 47(11):822-34. PubMed ID: 18381587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
    Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
    Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.